Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe
MSD joins as anchor customer as Aurobindo strengthens its position in the fast-growing global biologics manufacturing market
The drug currently approved for chronic kidney disease (CKD) associated with type 2 diabetes, may benefit a much broader group of patients than previously recognized
Targeting deadly drug-resistant acinetobacter infections
Following the completion of the acquisition on June 3, Noctrix’s flagship product, Nidra will become part of ResMed’s broader sleep medicine portfolio
Industry body aims to strengthen policy advocacy, innovation, and global competitiveness of India's fast-growing CRDMO sector
The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases
At the center of the project is a new cosmetics line developed through collaboration between industry and medicine
DCGI-approved semaglutide syringes for diabetes and obesity expand treatment choices and improve affordability
The approval is expected to support the company’s presence in regulated international markets and further strengthen its position as a reliable pharma manufacturing partner
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
